Fayez Sarofim & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $402M | Buy |
|
|||||
|
2025
Q1 | $454M | Sell |
|
|||||
|
2024
Q4 | $392M | Buy |
|
|||||
|
2024
Q3 | $405M | Buy |
|
|||||
|
2024
Q2 | $348M | Buy |
|
|||||
|
2024
Q1 | $351M | Sell |
|
|||||
|
2023
Q4 | $337M | Sell |
|
|||||
|
2023
Q3 | $298M | Buy |
|
|||||
|
2023
Q2 | $257M | Sell |
|
|||||
|
2023
Q1 | $331M | Buy |
|
|||||
|
2022
Q4 | $327M | Sell |
|
|||||
|
2022
Q3 | $296M | Sell |
|
|||||
|
2022
Q2 | $338M | Sell |
|
|||||
|
2022
Q1 | $359M | Buy |
|
|||||
|
2021
Q4 | $299M | Buy |
|
|||||
|
2021
Q3 | $237M | Sell |
|
|||||
|
2021
Q2 | $271M | Sell |
|
|||||
|
2021
Q1 | $318M | Sell |
|
|||||
|
2020
Q4 | $328M | Sell |
|
|||||
|
2020
Q3 | $279M | Sell |
|
|||||
|
2020
Q2 | $337M | Buy |
|
|||||
|
2020
Q1 | $232M | Sell |
|
|||||
|
2019
Q4 | $283M | Sell |
|
|||||
|
2019
Q3 | $249M | Sell |
|
|||||
|
2019
Q2 | $244M | Sell |
|
|||||
|
2019
Q1 | $274M | Sell |
|
|||||
|
2018
Q4 | $317M | Sell |
|
|||||
|
2018
Q3 | $329M | Sell |
|
|||||
|
2018
Q2 | $328M | Sell |
|
|||||
|
2018
Q1 | $343M | Buy |
|
|||||
|
2017
Q4 | $346M | Sell |
|
|||||
|
2017
Q3 | $329M | Sell |
|
|||||
|
2017
Q2 | $269M | Sell |
|
|||||
|
2017
Q1 | $248M | Sell |
|
|||||
|
2016
Q4 | $263M | Sell |
|
|||||
|
2016
Q3 | $277M | Sell |
|
|||||
|
2016
Q2 | $280M | Sell |
|
|||||
|
2016
Q1 | $258M | Buy |
|
|||||
|
2015
Q4 | $261M | Sell |
|
|||||
|
2015
Q3 | $246M | Sell |
|
|||||
|
2015
Q2 | $318M | Sell |
|
|||||
|
2015
Q1 | $288M | Sell |
|
|||||
|
2014
Q4 | $330M | Sell |
|
|||||
|
2014
Q3 | $301M | Sell |
|
|||||
|
2014
Q2 | $299M | Sell |
|
|||||
|
2014
Q1 | $275M | Sell |
|
|||||
|
2013
Q4 | $287M | Buy |
|
|||||
|
2013
Q2 | $231M | Buy |
|